Company News

Allergan, DOJ Settle Botox Investigation

To pay $600 million for misbranding, resolution of civil claims.

Author Image

By: TOM BRANNA

Editor

Allergan has reached a resolution with the U.S. Department of Justice (DOJ) regarding the previously reported government investigation into Allergan’s past U.S. sales and marketing practices relating to certain therapeutic uses of Botox. Allergan has been cooperating with the government in a multi-year investigation in Atlanta, GA, regarding the use of Botox for certain therapeutic treatments. Allergan has agreed to plead guilty to a single misdemeanor “misbranding” char...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters